BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7940808)

  • 1. Enalapril and cyclosporin in renal transplant patients and rats.
    Ferguson CJ; von Ruhland C; Shrestha B; Griffin PJ; Moore RH; Salaman JR
    Transplant Proc; 1994 Oct; 26(5):2600-1. PubMed ID: 7940808
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nifedipine on renal haemodynamics and urinary protein excretion in stable renal transplant recipients.
    Wilkie ME; Beer JC; Raftery MJ; Dawnay A; Barton C; Marsh FP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):612-5. PubMed ID: 8438435
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term effects of cyclosporine on hemodynamic parameters of renal allograft recipients.
    Abbud-Filho M; Barberato JB; Ramalho HJ; Salgueiro MC; Yamazaki WM; Paiva EV; Corrente JE; Bezas AG
    Transplant Proc; 1992 Oct; 24(5):1722-3. PubMed ID: 1412810
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal effects of L-arginine infusion in cyclosporine-treated transplant recipients.
    Viganò E; Badalamenti S; Paone G; Como G; Finazzi S; Tarantino A; Galmarini D; Ponticelli C
    Transplant Proc; 1994 Oct; 26(5):2622-3. PubMed ID: 7940816
    [No Abstract]   [Full Text] [Related]  

  • 5. The beneficial effects of isradipine on renal hemodynamics in cyclosporine-treated renal transplant recipients.
    McCrea JB; Francos GF; Burke JF; Michael HJ; Besarab A
    Transplantation; 1993 Mar; 55(3):672-4. PubMed ID: 8456491
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
    Lloveras JJ; Durand D; Ader JL; Tran Van T; Rostaing L; Cerene A; Fournial G; Suc JM
    Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of glomerular filtration rate after multiple administration of a new oral formulation of cyclosporine in clinically stable renal transplant patients.
    Mueller EA; Kallay Z; Kovarik JM; Arns W; Renner E; Kutz K
    Transplant Proc; 1995 Feb; 27(1):834-6. PubMed ID: 7879198
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral cimetidine improves the accuracy of creatinine clearance in transplant patients on cyclosporine.
    Marcen R; Serrano P; Teruel JL; Rivera ME; Mitjavila M; Navarro J; Orofino L; Sabater J; Ortuño J
    Transplant Proc; 1994 Oct; 26(5):2624-5. PubMed ID: 7940817
    [No Abstract]   [Full Text] [Related]  

  • 10. Stability of renal allograft glomerular filtration rate in the cyclosporine era: 2-year follow-up.
    Lewis R; Podbielski J; Munsell M; Katz S; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):2619-21. PubMed ID: 7940815
    [No Abstract]   [Full Text] [Related]  

  • 11. The beneficial effect of enalapril on erythrocytosis after renal transplantation.
    Conlon PJ; Farrell J; Donohoe J; Walshe JJ
    Transplantation; 1993 Jul; 56(1):217-9. PubMed ID: 8333046
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of different methods of estimating glomerular filtration rate in cyclosporine-treated renal transplant patients.
    Germain MJ; Lipkowitz GS; Guarnera J; Fiorentino J
    Transplantation; 1993 Jan; 55(1):203-5. PubMed ID: 8420049
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine-A-based immunosuppression and renal functional reserve in organ-transplant patients.
    Kamar N; Allard J; Ader JL; Rostaing L
    Transplant Proc; 2004 Mar; 36(2 Suppl):248S-250S. PubMed ID: 15041347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral content in cyclosporine-treated renal transplant patients.
    Massari PU; Garay G; Ulla MR
    Transplant Proc; 1994 Oct; 26(5):2646-8. PubMed ID: 7940826
    [No Abstract]   [Full Text] [Related]  

  • 18. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT
    Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.